Abstract 3464: CEBPD (C/EBPδ) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy.

Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis

Oncotarget ◽

10.18632/oncotarget.26348 ◽

2018 ◽

Vol 9 (91) ◽

pp. 36331-36343 ◽

Cited By ~ 12

Author(s):

Wei Sha ◽

Yanfei Zhou ◽

Zhi-Qiang Ling ◽

Guiqin Xie ◽

Xiaowu Pang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Hormone Receptor ◽

Breast Cancer Cells ◽

Triple Negative ◽

Salvianolic Acid B ◽

Salvianolic Acid ◽

Antitumor Properties ◽

Abstract PD7-12: Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells

10.1158/1538-7445.sabcs18-pd7-12 ◽

2019 ◽

Cited By ~ 2

Author(s):

C Guarducci ◽

A Nardone ◽

A Feiglin ◽

I Migliaccio ◽

L Malorni ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Hormone Receptor ◽

Breast Cancer Cells ◽

Abstract P2-18-01: Single modality adjuvant therapy with radiation (RT) alone or endocrine therapy (ET) alone in women ≥65 years with early stage, hormone receptor positive breast cancer treated with breast-conserving surgery: A population-based analysis

10.1158/1538-7445.sabcs19-p2-18-01 ◽

2020 ◽

Author(s):

Mira Goldberg ◽

Rinku Sutradhar ◽

Lawrence Paszat ◽

Timothy Whelan ◽

Sumei Gu ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Early Stage ◽

Breast Conserving Surgery ◽

Population Based ◽

Single Modality ◽

Goserelin versus CMF as adjuvant therapy for node-negative, hormone receptor-positive breast cancer in premenopausal patients. The GABG IV-A-93 trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.534 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 534-534 ◽

Cited By ~ 1

Author(s):

G. Von Minckwitz ◽

E. Graf ◽

M. Geberth ◽

W. Eiermann ◽

W. Jonat ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Hormone Receptor ◽

Node Negative ◽

Premenopausal Patients ◽

5201 POSTER The EXpand Study – Effect of Zoledronic Acid on Prevention of Bone Loss, During Extended Adjuvant Therapy With Letrozole in Postmenopausal Women With Primary Hormone Receptor Positive Breast Cancer Compared to Letrozole Alone

European Journal of Cancer ◽

10.1016/s0959-8049(11)71643-4 ◽

2011 ◽

Vol 47 ◽

pp. S390 ◽

Cited By ~ 1

Author(s):

M. Hellrieqel ◽

M. Mueller ◽

T. Reimer ◽

D.T. Baerens ◽

A. von der Assen ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Prevention Of Bone Loss ◽

Extended Adjuvant Therapy ◽

Immediate optimal endocrine adjuvant therapy versus standard chemotherapy followed by the same endocrine therapy in pre- or peri-menopausal patients with early hormone receptor-positive breast cancer - the Promise study

http://isrctn.org/> ◽

10.1186/isrctn23561723 ◽

2012 ◽

Author(s):

J.G.M. Klijn

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Standard Chemotherapy ◽

Abstract P3-04-10: Progesterone receptor (PR) blockade by antiprogestin, CDB4124 in hormone receptor positive breast cancer cells leads to significant inhibition of G2/M cell cycle genes

10.1158/1538-7445.sabcs14-p3-04-10 ◽

2015 ◽

Author(s):

Akash Gupa ◽

Mi Ran Choi ◽

Susan E Clare ◽

Jun Wang ◽

Oukseub Lee ◽

...

Keyword(s):

Breast Cancer ◽

Cell Cycle ◽

Progesterone Receptor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Significant Inhibition ◽

M Cell ◽

Cell Cycle Genes ◽

Abstract P4-04-03: High-throughput epigenetic screening in hormone receptor positive (HR+) breast cancer cells

10.1158/1538-7445.sabcs19-p4-04-03 ◽

2020 ◽

Author(s):

Fengting Yan ◽

Olga Nikolova ◽

VK Gadi

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

High Throughput ◽

Hormone Receptor ◽

Breast Cancer Cells ◽

Hormone Receptor Positive

PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

Value in Health ◽

10.1016/j.jval.2012.03.1186 ◽

2012 ◽

Vol 15 (4) ◽

pp. A220

Author(s):

S.D. Sura ◽

S.S. Sansgiry

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Hormone Receptor ◽

Early Stage ◽

Effectiveness Analysis ◽

Adoption Patterns and Predictors of De-escalated Adjuvant Therapy for Older Women With Early Stage Hormone Receptor Positive Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1612 ◽

2017 ◽

Vol 99 (2) ◽

pp. E422

Author(s):

T.M. Zagar ◽

C. Baggett ◽

S. Wheeler ◽

X. Zhou ◽

A.M. Meyer ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Older Women ◽

Hormone Receptor ◽

Early Stage ◽